C-Reactive Protein a Promising Biomarker of COVID-19 Severity
The 2019 coronavirus outbreak poses a threat to scientific, societal, financial, and health resources. The complex pathogenesis of severe acute respiratory syndrome coronavirus centers on the unpredictable clinical progression of the disease, which may evolve abruptly and result in critical and life-threatening clinical complications. Effective clinical laboratory biomarkers that can classify patients according to risk are essential for ensuring timely treatment, and an analysis of recently published studies found cytokine storm and coagulation disorders were leading factors of severe COVID-19 complications. The following inflammatory, biochemical, and hematology biomarkers markers have been identified in COVID-19 patients; neutrophil to lymphocyte ratio, c-reactive protein, procalcitonin, urea, liver enzymes, lactate dehydrogenase, serum amyloid A, cytokines, d-dimer, fibrinogen, ferritin, troponin, creatinine kinase, and lymphocyte, leukocyte, and platelet counts. These factors are predictors of disease severity and some are involved in the pathogenesis of COVID-19. CRP is an acute-phase, non-specific serological biomarker of inflammation and infection and is related to disease severities and outcomes. In the present study, CRP levels were found to rise dramatically among COVID-19 patients, and our findings suggest CRP could be utilized clinically to predict COVID-19 prognosis and severity even before disease progression and the manifestation of clinical symptoms..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Korean Journal of Clinical Laboratory Science - 53(2021), 3, Seite 201-207 |
| Sprache: |
Englisch ; Koreanisch |
|---|
| Beteiligte Personen: |
Muntaha Fazal [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.15324/kjcls.2021.53.3.201 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ062244264 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ062244264 | ||
| 003 | DE-627 | ||
| 005 | 20230309020116.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15324/kjcls.2021.53.3.201 |2 doi | |
| 035 | |a (DE-627)DOAJ062244264 | ||
| 035 | |a (DE-599)DOAJ396bc9fcf3244bf6b0cad548bf981cc1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a kor | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Muntaha Fazal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a C-Reactive Protein a Promising Biomarker of COVID-19 Severity |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The 2019 coronavirus outbreak poses a threat to scientific, societal, financial, and health resources. The complex pathogenesis of severe acute respiratory syndrome coronavirus centers on the unpredictable clinical progression of the disease, which may evolve abruptly and result in critical and life-threatening clinical complications. Effective clinical laboratory biomarkers that can classify patients according to risk are essential for ensuring timely treatment, and an analysis of recently published studies found cytokine storm and coagulation disorders were leading factors of severe COVID-19 complications. The following inflammatory, biochemical, and hematology biomarkers markers have been identified in COVID-19 patients; neutrophil to lymphocyte ratio, c-reactive protein, procalcitonin, urea, liver enzymes, lactate dehydrogenase, serum amyloid A, cytokines, d-dimer, fibrinogen, ferritin, troponin, creatinine kinase, and lymphocyte, leukocyte, and platelet counts. These factors are predictors of disease severity and some are involved in the pathogenesis of COVID-19. CRP is an acute-phase, non-specific serological biomarker of inflammation and infection and is related to disease severities and outcomes. In the present study, CRP levels were found to rise dramatically among COVID-19 patients, and our findings suggest CRP could be utilized clinically to predict COVID-19 prognosis and severity even before disease progression and the manifestation of clinical symptoms. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a c-reactive protein | |
| 650 | 4 | |a severity | |
| 653 | 0 | |a Medicine (General) | |
| 773 | 0 | 8 | |i In |t Korean Journal of Clinical Laboratory Science |d The Korean Society for Clinical Laboratory Science, 2020 |g 53(2021), 3, Seite 201-207 |w (DE-627)DOAJ000015962 |x 22881662 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2021 |g number:3 |g pages:201-207 |
| 856 | 4 | 0 | |u https://doi.org/10.15324/kjcls.2021.53.3.201 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/396bc9fcf3244bf6b0cad548bf981cc1 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1738-3544 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2288-1662 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2021 |e 3 |h 201-207 | ||